Selected research
Industry Research
Swine Epidemic Diarrhea Vaccines Industry Research Report 2026
Market perspective
The global Swine Epidemic Diarrhea Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Swine Epidemic Diarrhea Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Swine Epidemic Diarrhea Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Swine Epidemic Diarrhea Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Swine Epidemic Diarrhea Vaccines include CAVAC, Qilu Animal Health, Zoetis, Nisseiken, Komipharm, Harrisvaccines, Inc. and Green Cross Veterinary Products, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Swine Epidemic Diarrhea Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Swine Epidemic Diarrhea Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Swine Epidemic Diarrhea Vaccines Market by Company
CAVAC
Qilu Animal Health
Zoetis
Nisseiken
Komipharm
Harrisvaccines, Inc.
Green Cross Veterinary Products
Swine Epidemic Diarrhea Vaccines Segment by Type
Live Vaccines
Killed Vaccines
Swine Epidemic Diarrhea Vaccines Segment by Application
Piglets
Adults Pigs
Swine Epidemic Diarrhea Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Epidemic Diarrhea Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Epidemic Diarrhea Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Epidemic Diarrhea Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Swine Epidemic Diarrhea Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Piglets
- Adults Pigs
Companies covered
- CAVAC
- Qilu Animal Health
- Zoetis
- Nisseiken
- Komipharm
- Harrisvaccines, Inc.
- Green Cross Veterinary Products
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Swine Epidemic Diarrhea Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Live Vaccines
- 2.2.3 Killed Vaccines
- 2.3 Swine Epidemic Diarrhea Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Piglets
- 2.3.3 Adults Pigs
- 2.4 Assumptions and Limitations
3 Swine Epidemic Diarrhea Vaccines Breakdown Data by Type
- 3.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2027-2032)
4 Swine Epidemic Diarrhea Vaccines Breakdown Data by Application
- 4.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Swine Epidemic Diarrhea Vaccines Market Perspective (2021-2032)
- 5.2 Global Swine Epidemic Diarrhea Vaccines Growth Trends by Region
- 5.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Swine Epidemic Diarrhea Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Swine Epidemic Diarrhea Vaccines Market Dynamics
- 5.3.1 Swine Epidemic Diarrhea Vaccines Industry Trends
- 5.3.2 Swine Epidemic Diarrhea Vaccines Market Drivers
- 5.3.3 Swine Epidemic Diarrhea Vaccines Market Challenges
- 5.3.4 Swine Epidemic Diarrhea Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue
- 6.1.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Swine Epidemic Diarrhea Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Swine Epidemic Diarrhea Vaccines Head Office and Area Served
- 6.4 Global Swine Epidemic Diarrhea Vaccines Players, Product Type & Application
- 6.5 Global Swine Epidemic Diarrhea Vaccines Manufacturers Established Date
- 6.6 Global Swine Epidemic Diarrhea Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 7.2 North America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 7.4 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 8.2 Europe Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 10.2 South America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 10.4 South America Swine Epidemic Diarrhea Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CAVAC
- 12.1.1 CAVAC Company Information
- 12.1.2 CAVAC Business Overview
- 12.1.3 CAVAC Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.1.4 CAVAC Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.1.5 CAVAC Recent Developments
- 12.2 Qilu Animal Health
- 12.2.1 Qilu Animal Health Company Information
- 12.2.2 Qilu Animal Health Business Overview
- 12.2.3 Qilu Animal Health Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.2.4 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.2.5 Qilu Animal Health Recent Developments
- 12.3 Zoetis
- 12.3.1 Zoetis Company Information
- 12.3.2 Zoetis Business Overview
- 12.3.3 Zoetis Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.3.4 Zoetis Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.3.5 Zoetis Recent Developments
- 12.4 Nisseiken
- 12.4.1 Nisseiken Company Information
- 12.4.2 Nisseiken Business Overview
- 12.4.3 Nisseiken Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.4.4 Nisseiken Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.4.5 Nisseiken Recent Developments
- 12.5 Komipharm
- 12.5.1 Komipharm Company Information
- 12.5.2 Komipharm Business Overview
- 12.5.3 Komipharm Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.5.4 Komipharm Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.5.5 Komipharm Recent Developments
- 12.6 Harrisvaccines, Inc.
- 12.6.1 Harrisvaccines, Inc. Company Information
- 12.6.2 Harrisvaccines, Inc. Business Overview
- 12.6.3 Harrisvaccines, Inc. Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.6.4 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.6.5 Harrisvaccines, Inc. Recent Developments
- 12.7 Green Cross Veterinary Products
- 12.7.1 Green Cross Veterinary Products Company Information
- 12.7.2 Green Cross Veterinary Products Business Overview
- 12.7.3 Green Cross Veterinary Products Revenue in Swine Epidemic Diarrhea Vaccines Business (2021-2026)
- 12.7.4 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product Portfolio
- 12.7.5 Green Cross Veterinary Products Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst